ORAL PROTEIN KINASE C β INHIBITION USING RUBOXISTAURIN-Reference-Cited by-同舟云学术

ORAL PROTEIN KINASE C β INHIBITION USING RUBOXISTAURIN

Published:2011-11 Issue:10 Volume:31 Page:2084-2094
ISSN:0275-004X
Container-title:Retina
language:en
Short-container-title:

Author:

Aiello Lloyd Paul,Vignati Louis,Sheetz Matthew J,Zhi Xin,Girach Aniz,Davis Matthew D,Wolka Anne M,Shahri Nazila,Milton Roy C

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology,General Medicine

Reference16 articles.

1. Protein kinase C and the development of diabetic vascular complications.;Way;Diabet Med,2001

2. Molecular understanding of hyperglycemias adverse effects for diabetic complications.;Sheetz;JAMA,2002

3. Biochemical pathways for microvascular complications of diabetes mellitus.;Setter;Ann Pharmacother,2003

4. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor.;Aiello;Diabetes,1997

5. Inhibition of intraocular neovascularization caused by retinal ischemia in pigs by PKC beta inhibition with LY333531.;Danis;Invest Ophthalmol Vis Sci,1998

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glycative stress as a cause of macular degeneration;Progress in Retinal and Eye Research;2024-07

2. C2CD4B Evokes Oxidative Stress and Vascular Dysfunction via a PI3K/Akt/PKCα–Signaling Pathway;Antioxidants;2024-01-14

3. An Update on Protein Kinases as Therapeutic Targets—Part I: Protein Kinase C Activation and Its Role in Cancer and Cardiovascular Diseases;International Journal of Molecular Sciences;2023-12-18

4. Diabetes, Diabetic Retinopathy, and Inflammatory Disorders;Ocular Immunology and Inflammation;2023-05-09

5. Diabetes Mellitus Associated Progressive Neurovascular Retinal Injury;Retina Lasers in Ophthalmology;2023